HAP Trading’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-35,000	Closed	-$118K	–	899
2024 Q1	$118K	Buy	+35,000	New	+$2.41M	0.01%	339
2021 Q4	–	Sell	-27,800	Closed	-$121K	–	2933
2021 Q3	$121K	Buy	27,800 +13,000	+88%	+$452K	﹤0.01%	1203
2021 Q2	$40K	Buy	+14,800	New	+$547K	﹤0.01%	1560
2021 Q1	–	Sell	-54,200	Closed	-$20K	–	2659
2020 Q4	$20K	Sell	54,200 -9,200	-15%	-$242K	﹤0.01%	1708
2020 Q3	$274K	Sell	63,400 -258,700	-80%	-$5.9M	0.01%	547
2020 Q2	$640K	Buy	+322,100	New	+$6.52M	0.04%	373
2020 Q1	–	Sell	-2,559,500	Closed	-$22K	–	1556
2019 Q4	$22K	Buy	2,559,500 +843,800	+49%	+$10.1M	﹤0.01%	863
2019 Q3	$716K	Buy	1,715,700 +1,546,600	+915%	+$14.8M	0.06%	256
2019 Q2	$73K	Buy	+169,100	New	+$2.17M	0.01%	660
2017 Q4	–	Sell	-50,600	Closed	-$102K	–	1195
2017 Q3	$102K	Buy	+50,600	New	+$743K	﹤0.01%	579
2016 Q4	–	Sell	-18,000	Closed	-$216K	–	1262
2016 Q3	$216K	Buy	+18,000	New	+$728K	0.01%	488